Your browser doesn't support javascript.
loading
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study.
Zeremski, Vanja; Jentsch-Ullrich, Kathleen; Kahl, Christoph; Mohren, Martin; Eberhardt, Judith; Fischer, Thomas; Schalk, Enrico.
Afiliação
  • Zeremski V; Department of Haematology and Oncology, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. vanja.zeremski@med.ovgu.de.
  • Jentsch-Ullrich K; Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Centre, Otto-von-Guericke University, Magdeburg, Germany. vanja.zeremski@med.ovgu.de.
  • Kahl C; Private Practice for Haematology and Oncology, Magdeburg, Germany.
  • Mohren M; Department of Haematology, Oncology and Palliative Care, Klinikum Magdeburg, Magdeburg, Germany.
  • Eberhardt J; Department of Hematology and Oncology, Johanniter Krankenhaus, Stendal, Germany.
  • Fischer T; Department of Haematology and Oncology, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
  • Schalk E; Health Campus Immunology, Infectiology and Inflammation (GC-I3), Medical Centre, Otto-von-Guericke University, Magdeburg, Germany.
Ann Hematol ; 98(12): 2729-2737, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31705183

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha